DNMT3B and hepatocellular carcinoma: Female HCC patients with the DNMT3B variant (−149 T) showed a much higher risk in developing HCC (OR (odds ratio): 1.97) compared to male patients (OR: 0.46), suggesting a possible genetic cause for the sex/gender disparity in HCC incidence, which may act by affecting the global DNA methylation status [39].